Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like San Diego's Denovo Biopharma Opens Doors to New R&D Center, Names New CMO and CFO January 2, 2018 EnteroMedics Announces Proposed Underwritten Public Offering August 10, 2017 Emergent BioSolutions Unveils Its Expanded Center For Innovation In Advanced Development And Manufacturing In Baltimore May 9, 2017
Emergent BioSolutions Unveils Its Expanded Center For Innovation In Advanced Development And Manufacturing In Baltimore May 9, 2017
